Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alfero... AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders, viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases and drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer and triple negative metastatic breast cancer. The company is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19. Mehr anzeigen
OCALA, Fla., Nov. 19, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that data were published on Roswell Park Comprehensive Cancer...
– Continued execution across Ampligen® clinical development programs in areas with critical unmet needs, especially in the high-value pancreatic cancer space – Driving significant momentum with...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.041 | -17.8260869565 | 0.23 | 0.2726 | 0.1801 | 987130 | 0.23382223 | CS |
| 4 | -0.081 | -30 | 0.27 | 0.2793 | 0.1801 | 415153 | 0.243916 | CS |
| 12 | -0.1802 | -48.8082340195 | 0.3692 | 0.38 | 0.1801 | 333550 | 0.26219829 | CS |
| 26 | -0.231 | -55 | 0.42 | 0.469 | 0.1801 | 315227 | 0.31832051 | CS |
| 52 | -0.2465 | -56.6016073479 | 0.4355 | 0.62 | 0.1801 | 251770 | 0.36560363 | CS |
| 156 | -1.281 | -87.1428571429 | 1.47 | 1.51 | 0.1801 | 230999 | 0.66597772 | CS |
| 260 | -0.276 | -59.3548387097 | 0.465 | 8.75 | 0.1801 | 1357371 | 2.49058035 | CS |
| Keine Diskussionen Gefunden. |
| Neuen Thread Erstellen |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
